PRCT
Procept Biorobotics Corp
NASDAQ: PRCT · HEALTHCARE · MEDICAL DEVICES
$21.71
-5.73% today
Updated 2026-04-29
Market cap
$1.24B
P/E ratio
—
P/S ratio
4.01x
EPS (TTM)
$-1.72
Dividend yield
—
52W range
$19 – $67
Volume
1.8M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B6.3
Quality
B2.0
Profitability
F4.0
Valuation
C5/9
Piotroski F-Score
Moderate
1.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$30.89
+42.28%
12-Month target
—
—
Intrinsic (DCF)
$23.22
Margin of safety
-22.74%
1 Strong Buy6 Buy4 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 11.90% QoQ
Risks
- Altman Z 1.41 — distress zone
- Thin margins at -31.00%
- Negative free cash flow $-12.18M
- 22.74% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $75.01M | $136.19M | $224.50M | $308.05M | $308.05M |
| Net income | $-87.15M | $-105.90M | $-91.41M | $-95.57M | $-29.84M |
| EPS | — | — | — | — | $-1.72 |
| Free cash flow | $-83.03M | $-133.21M | $-103.62M | $-58.34M | $-12.18M |
| Profit margin | -116.18% | -77.76% | -40.72% | -31.02% | -31.00% |
Peer comparison
Smart narrative
Procept Biorobotics Corp trades at $21.71. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.41, it sits in the distress. TTM revenue stands at $308.05M. with profit margins at -31.00%. Our DCF model estimates intrinsic value at $23.22.
Frequently asked questions
What is Procept Biorobotics Corp's stock price?
Procept Biorobotics Corp (PRCT) trades at $21.71.
Is Procept Biorobotics Corp overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $23.22.
What is the price target of Procept Biorobotics Corp (PRCT)?
The analyst target price is $30.89, representing +42.3% upside from the current price of $21.71.
What is the intrinsic value of Procept Biorobotics Corp (PRCT)?
Based on our DCF model, intrinsic value is $23.22, a -22.7% margin of safety versus $21.71.
What is Procept Biorobotics Corp's revenue?
TTM revenue is $308.05M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.41 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.01x
ROE-24.90%
Beta0.93
50D MA$25.29
200D MA$33.64
Shares out0.06B
Float0.06B
Short ratio—
Avg volume1.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—